ClinicalTrials.Veeva

Menu

DNA Methylation Biomarkers for Cervical Cancer Screening

I

iStat Biomedical

Status

Unknown

Conditions

Cervical Intraepithelial Neoplasia
Cervical Cancer

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02605941
epigene-13151

Details and patient eligibility

About

The purpose of this prospective study is to evaluate whether DNA methylation can be applied in cervical cancer screening.

Enrollment

5,000 estimated patients

Sex

Female

Ages

20+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • women with age ≥20 and sexual experience
  • Agree to sign ICF

Exclusion criteria

  • women had received Hysterectomy
  • women had destructive therapy for cervical lesions in 6 months, for examples: conization, Laser or cryotherapy, chemotherapy, and radiation therapy
  • Women are at pregnancy or had baby delivery in 6 weeks

Trial contacts and locations

1

Loading...

Central trial contact

Chien-Ping Hung; Hsiu-yuan Tsao

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems